🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,301 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8022094

Carvedilol phosphate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8007774

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic poly

REGENTIS BIOMATERIALS LTD. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994178

Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994360

Benzofuran compounds

XTL BIOPHARMACEUTICALS LTD. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7989473

Stable laquinimod preparations

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7981513

Dental filler

JGC Catalysts and Chemicals Ltd. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7977457

Fusion proteins, uses thereof and processes for producing same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7972543

Process for producing microsphere with use of metal substrate having through-hole

KURARAY CO., LTD. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7973045

Anhydrous form of dasatinib and process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968511

Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968749

Process for preparing and drying solid rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964748

Process for preparing intermediates of HMG-CoA reductase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960586

Purification of armodafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951557

Human lysosomal proteins from plant cell culture

Protalix Ltd. · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943131

Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

GENERAL REGENERATIVES, LTD. · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7939495

Method for improving skin conditions

CAREGEN CO., LTD. · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7923215

Process for the measurement of the potency of glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7923004

4-ethynyl pyrazole derivative compounds and methods for treatment of HCV

XTL BIOPHARMACEUTICALS LTD. · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915412

Process for the synthesis of 9-hydroxy risperidone (paliperidone)

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915423

Solid states of pantoprazole sodium, processes for preparing them and processes for prepar

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892008

Electrical connector having metallic lock

Hon Hai Precision Ind. Co., Ltd. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884226

Purification of rosuvatatin intermediate by thin film evaporation and chemical method

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884208

Crystals of laquinimod sodium, and process for the manufacture thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871993

Tigecycline crystalline forms and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted